| 1 | ENALAPRIL VALSARTAN METHYLPREDNISONE | [3] Enalapril Enalapril, Methylprednisone (Methylprednisone), Valsartan | [3] Valsartan
Valsartan
,
Enalapril maleate
,
Enalapril
💬
| [2] ACE ACE, AGTR1 💬
| [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 2 | Methylprednisone | [1] Methylprednisone Methylprednisone (Methylprednisone) | - | - | - | [4] 46 46, 66, 85, 222 💬
|
| 3 | Methylprednisone/Prednisone | [2] Methylprednisone Methylprednisone (Methylprednisone), Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 85 85 💬
|
| 4 | Prednisone,methylprednisone and cyclophosphamide | [3] Cyclophosphamide Cyclophosphamide, Methylprednisone (Methylprednisone), Prednisone | [3] Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|